# SRR

## Overview
The SRR gene encodes the enzyme serine racemase, which is a pyridoxal phosphate-dependent enzyme responsible for the conversion of L-serine to D-serine. D-serine serves as a co-agonist for the N-methyl-D-aspartate (NMDA) receptor, playing a critical role in modulating synaptic plasticity, learning, and memory (Wolosker1999Serine). Serine racemase is primarily expressed in neurons and glial cells, including astrocytes, and is active in both the cytoplasm and mitochondria (Miya2008Serine; Wolosker1999Serine). The enzyme's activity is regulated through interactions with various proteins and post-translational modifications, which influence its stability and function (Kim2005Serine; Raboni2019The). Alterations in the SRR gene have been linked to several neurological and psychiatric disorders, highlighting its significance in both normal and pathological brain function (Cui2022Integrated; Labrie2009Serine).

## Structure
Serine racemase (SRR) is an enzyme that catalyzes the conversion of L-serine to D-serine, a co-agonist of NMDA receptors. The primary structure of SRR consists of a sequence of amino acids that form the basis for its functional conformation. The secondary structure of SRR includes alpha-helices and beta-sheets, which contribute to the enzyme's stability and function. The tertiary structure of SRR is characterized by the formation of a homodimer, which is essential for its enzymatic activity. This dimerization is facilitated by specific interactions between the monomer units, allowing the enzyme to maintain its active conformation.

SRR contains a pyridoxal phosphate (PLP) binding domain, which is crucial for its catalytic activity. PLP acts as a cofactor, enabling the enzyme to facilitate the racemization of serine. Common post-translational modifications of SRR include phosphorylation, which can regulate its activity and stability. These modifications may influence the enzyme's interaction with other cellular components and its overall function within the cell. The structural features of SRR, including its domain organization and post-translational modifications, are integral to its role in modulating NMDA receptor activity through the production of D-serine.

## Function
Serine racemase (SRR) is an enzyme that catalyzes the conversion of L-serine to D-serine, a crucial co-agonist of the N-methyl-D-aspartate (NMDA) receptor in the brain. This conversion is essential for the regulation of glutamate neurotransmission, which is vital for synaptic plasticity, learning, and memory (Wolosker1999Serine). D-serine, produced by SRR, acts at the glycine site of NMDA receptors, enhancing their activity and influencing neural network formation and synaptic function (Inoue2008NMDA; Miya2008Serine).

SRR is primarily localized in neurons and glial cells, including astrocytes, where it plays a significant role in maintaining adequate levels of D-serine for normal brain function (Miya2008Serine; Wolosker1999Serine). The enzyme's activity is dependent on pyridoxal-5'-phosphate, a cofactor necessary for its function (Wolosker1999Serine). In the cellular context, SRR is active in the cytoplasm and mitochondria, where it contributes to the modulation of NMDA receptor-mediated processes, such as synaptic transmission and plasticity (Wolosker1999Serine). The regulation of SRR and D-serine levels is influenced by various factors, including neuronal activity and inflammatory stimuli, highlighting its role in both normal and pathological conditions (Miya2008Serine).

## Clinical Significance
Mutations and alterations in the SRR gene have been implicated in several diseases. In endometrial cancer, SRR expression is linked to various cellular processes, including DNA damage repair and ferroptosis. Higher SRR expression is associated with better prognoses and increased sensitivity to certain chemotherapeutic drugs, suggesting its potential as a prognostic biomarker and therapeutic target in uterine corpus endometrial carcinoma (UCEC) (Cui2022Integrated).

In schizophrenia, a genetic variant in the SRR gene is associated with reduced D-serine levels, which are crucial for normal neurotransmission through NMDA receptors. This reduction is linked to behavioral and cognitive deficits characteristic of schizophrenia, such as social dysfunction and impaired spatial recognition. The Srr Y269Ã mouse model, which exhibits altered D-serine levels, has been used to study these effects and test potential therapies (Labrie2009Serine).

The SRR gene is also associated with temporal lobe epilepsy (TLE). A specific intronic variation, rs4523957, has been identified as a protective marker against TLE, associated with reduced seizure frequency and lower drug-resistant incidence (Tao2018SRRintronic).

## Interactions
Serine racemase (SRR) interacts with several proteins that regulate its activity and stability. One key interaction is with the Glutamate Receptor Interacting Protein (GRIP), which binds to the C-terminal region of SRR via its PDZ domain. This interaction enhances SRR activity and D-serine release, which is crucial for neuronal migration and NMDA receptor-mediated neurotransmission (Kim2005Serine; Canu2014Serine). 

SRR also interacts with Protein Interacting with C-kinase 1 (PICK1), another PDZ domain-containing protein. PICK1 affects D-serine levels and SRR localization, playing a role in the regulation of synaptic function (Raboni2019The; Canu2014Serine). 

Other proteins, such as Stargazin and postsynaptic density protein 95 (PSD-95), form complexes with SRR, potentially influencing its activity and localization within the cell (Raboni2019The). Golga-3 and Disrupted in Schizophrenia 1 (DISC1) are involved in stabilizing SRR levels by inhibiting its ubiquitination, thereby preventing its degradation (Raboni2019The). 

These interactions highlight the complex regulatory network surrounding SRR, which is essential for its role in neurotransmission and cellular processes.


## References


[1. (Kim2005Serine) Paul M. Kim, Hiroyuki Aizawa, Peter S. Kim, Alex S. Huang, Sasrutha R. Wickramasinghe, Amir H. Kashani, Roxanne K. Barrow, Richard L. Huganir, Anirvan Ghosh, and Solomon H. Snyder. Serine racemase: activation by glutamate neurotransmission via glutamate receptor interacting protein and mediation of neuronal migration. Proceedings of the National Academy of Sciences, 102(6):2105–2110, January 2005. URL: http://dx.doi.org/10.1073/pnas.0409723102, doi:10.1073/pnas.0409723102. This article has 188 citations.](https://doi.org/10.1073/pnas.0409723102)

[2. (Miya2008Serine) Kazushi Miya, Ran Inoue, Yoshimi Takata, Manabu Abe, Rie Natsume, Kenji Sakimura, Kazuhisa Hongou, Toshio Miyawaki, and Hisashi Mori. Serine racemase is predominantly localized in neurons in mouse brain. Journal of Comparative Neurology, 510(6):641–654, August 2008. URL: http://dx.doi.org/10.1002/cne.21822, doi:10.1002/cne.21822. This article has 213 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/cne.21822)

[3. (Tao2018SRRintronic) Hua Tao, Xu Zhou, Qian Xie, Zhonghua Ma, Fuhai Sun, Lili Cui, Yujie Cai, Guoda Ma, Jiawu Fu, Zhou Liu, You Li, Haihong Zhou, Jianghao Zhao, Yanyan Chen, Hui Mai, Ying Chen, Jun Chen, Wei Qi, Chaowen Sun, Bin Zhao, and Keshen Li. <scp>srr</scp>intronic variation inhibits expression of its neighbouring<scp>smg</scp>6 gene and protects against temporal lobe epilepsy. Journal of Cellular and Molecular Medicine, 22(3):1883–1893, January 2018. URL: http://dx.doi.org/10.1111/jcmm.13473, doi:10.1111/jcmm.13473. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/jcmm.13473)

[4. (Canu2014Serine) Nadia Canu, Maria Teresa Ciotti, and Loredano Pollegioni. Serine racemase: a key player in apoptosis and necrosis. Frontiers in Synaptic Neuroscience, April 2014. URL: http://dx.doi.org/10.3389/fnsyn.2014.00009, doi:10.3389/fnsyn.2014.00009. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnsyn.2014.00009)

[5. (Wolosker1999Serine) Herman Wolosker, Seth Blackshaw, and Solomon H. Snyder. Serine racemase: a glial enzyme synthesizing <scp>d</scp> -serine to regulate glutamate- n -methyl- <scp>d</scp> -aspartate neurotransmission. Proceedings of the National Academy of Sciences, 96(23):13409–13414, November 1999. URL: http://dx.doi.org/10.1073/pnas.96.23.13409, doi:10.1073/pnas.96.23.13409. This article has 694 citations.](https://doi.org/10.1073/pnas.96.23.13409)

[6. (Raboni2019The) Samanta Raboni, Marialaura Marchetti, Serena Faggiano, Barbara Campanini, Stefano Bruno, Francesco Marchesani, Marilena Margiotta, and Andrea Mozzarelli. The energy landscape of human serine racemase. Frontiers in Molecular Biosciences, January 2019. URL: http://dx.doi.org/10.3389/fmolb.2018.00112, doi:10.3389/fmolb.2018.00112. This article has 28 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fmolb.2018.00112)

[7. (Inoue2008NMDA) Ran Inoue, Kenji Hashimoto, Tomomi Harai, and Hisashi Mori. Nmda- and β-amyloid1–42-induced neurotoxicity is attenuated in serine racemase knock-out mice. The Journal of Neuroscience, 28(53):14486–14491, December 2008. URL: http://dx.doi.org/10.1523/jneurosci.5034-08.2008, doi:10.1523/jneurosci.5034-08.2008. This article has 143 citations.](https://doi.org/10.1523/jneurosci.5034-08.2008)

[8. (Cui2022Integrated) Zhiwei Cui, Jiantao Mo, Lijun Wang, Rongli Wang, Feiyan Cheng, Lihui Wang, Xinyuan Yang, and Wei Wang. Integrated bioinformatics analysis of serine racemase as an independent prognostic biomarker in endometrial cancer. Frontiers in Genetics, July 2022. URL: http://dx.doi.org/10.3389/fgene.2022.906291, doi:10.3389/fgene.2022.906291. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2022.906291)

[9. (Labrie2009Serine) Viviane Labrie, Ryutaro Fukumura, Anjali Rastogi, Laura J. Fick, Wei Wang, Paul C. Boutros, James L. Kennedy, Mawahib O. Semeralul, Frankie H. Lee, Glen B. Baker, Denise D. Belsham, Steven W. Barger, Yoichi Gondo, Albert H.C. Wong, and John C. Roder. Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model. Human Molecular Genetics, 18(17):3227–3243, May 2009. URL: http://dx.doi.org/10.1093/hmg/ddp261, doi:10.1093/hmg/ddp261. This article has 151 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddp261)